by: Parent Project Muscular Dystrophy
WATCH: A Conversation with PTC Therapeutics (Webinar Recording)
PTC Therapeutics recently joined PPMD for a community webinar on Friday, December 9, 2022 for a discussion regarding PTC’s history with the community and plans for the future, including activities to bring ataluren (Translarna) to US patients with nonsense mutations.
If you missed the live event, the recording can be found below.
